GEHC · GE HealthCare Technologies Inc.
$71.98
+0.74% last session
End-of-day data · close of 2026-10-26
Market cap
$33B
Enterprise value
$41B
Trailing P/E
16.4
Forward P/E
13.2
Dividend yield
0.0%
Beta
0.85
Avg volume
4M
Employees
54K
Daily Change %
0.74%
5 Days Change
2.66%
10 Days Change
3.82%
30 Days Change
8.06%
60 Days Change
-3.73%
Month to Day Change
11.63%
Year to Day Change
-12.80%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — GEHC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-12
Latest call per bank · past 12 months
Barclays
Overweight$85.00
+19.0% vs priceCitigroup
Neutral$71.00
-0.6% vs priceUBS
Neutral$73.00
+2.2% vs priceWells Fargo
Overweight$85.00
+19.0% vs priceRBC Capital
Outperform$80.00
+12.0% vs priceJP Morgan
Neutral$65.00
-9.0% vs priceGoldman Sachs
Neutral$65.00
-9.0% vs priceMorgan Stanley
Equal-Weight$85.00
+19.0% vs priceBank of America
Neutral$92.00
+28.8% vs priceJefferies
Buy$105
+47.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | BTIG | Maintains | Buy | $79.00 → $75.00 |
| 2026-10-07 | Barclays | Initiates | Overweight | $0.00 → $85.00 |
| 2026-10-05 | Citigroup | Maintains | Neutral | $75.00 → $71.00 |
| 2026-10-05 | Needham | Reiterates | Buy | $93.00 |
| 2026-09-22 | Needham | Initiates | Buy | $0.00 → $93.00 |
| 2026-09-17 | BTIG | Reiterates | Buy | $79.00 |
| 2026-08-19 | BTIG | Reiterates | Buy | $79.00 |
| 2026-07-31 | UBS | Maintains | Neutral | $67.00 → $73.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-26
- neutral: RSI (14): RSI is 66 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 5.4% above the 50-day MA ($68.29).
- bullish: Price vs 200-day MA: Trading 2.9% above the 200-day MA ($69.96).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.58) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($59.42) and high ($87.98).
GEHC Price Chart
Loading chart for GEHC…
Fundamentals
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
More in Medical Devices
ABT
Abbott Laboratories
$179B -16.2% YTD
MDT
Medtronic plc.
$122B 3.1% YTD
SYK
Stryker Corporation
$118B -11.9% YTD
BSX
Boston Scientific Corporation
$66B -51.7% YTD
EW
Edwards Lifesciences Corporatio
$51B 5.7% YTD
DXCM
DexCom, Inc.
$29B 18.0% YTD
PHG
Koninklijke Philips N.V. NY Reg
$26B 3.3% YTD
STE
STERIS plc (Ireland)
$23B -7.6% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.